Regeneron Pharmaceuticals Inc. REGN,
It said late on Tuesday that the U.S. government had agreed to purchase an additional 1.25 million doses of the company’s COVID-19 antibody cocktail, which would increase the supply of US cocktails containing casirivimab and imdevimab antibodies to more than 1.5. Millions of doses under the new deal, the government will buy the cocktails in volumes for delivery by June 30.Regeneron has already provided the quantities to maintain about 300,000 people, with President Donald Trump being treated. When he fell ill with COVID-1
9 last year, “COVID-19 continues to make hundreds of thousands of Americans sick every day, and the people of Regeneron are committed to helping,” Chief Executive Leonard S. Schleifer said in a statement. “We are pleased to work with the US government to provide our antibody cocktail as a key weapon in this battle,” said the patient who received the cocktail in a clinical trial. “The virus levels were found to drop significantly and require fewer COVID-19 visits, suggesting that therapy could help reduce the current burden of hospitals and healthcare systems,” the company said. Cocktails are still being evaluated in clinical trials for the treatment of in- and out-of-hospital COVID-19 patients, including trials to prevent COVID-19 in households dealing with infected people.Regeneron’s shares have risen by nearly 5. % In the extended period after the end of the normal trading day increased 0.6%.